Pharvaris N.V. (PHVS)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Net income
- -175,699,397
- Operating income
- -173,711,496
- Earnings per share
- -2.97
- R&D expense
- 124,478,334
Growth and profitability
- Return on equity
- -64.77
- Return on assets
- -58.28
Balance sheet
- Total assets
- 301,454,999
- Total liabilities
- 30,180,665
- Shareholders' equity
- 271,274,334
- Cash and equivalents
- 291,678,888
Cash flow and ratios
- Operating cash flow
- -137,073,634
- Free cash flow
- -137,238,253
Shareholder returns
- Shares outstanding
- 65,210,590
- Book value per share
- 4.16
Company information
- Headquarters
- Leiden
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Pharvaris N.V. trades on NASDAQ under the ticker symbol PHVS. This page brings together its price chart, company profile, key financial figures and technical indicators.